Could a shot cure your pimples? mRNA vaccine for acne enters human trials

NCT ID NCT07013747

First seen Nov 01, 2025 · Last updated May 12, 2026 · Updated 29 times

Summary

This study tests an mRNA vaccine designed to treat mild acne. About 120 adults aged 18 to 45 with mild acne will receive two doses of the vaccine or a placebo. Researchers will check if the vaccine is safe, reduces acne lesions, and triggers an immune response. The study includes a long-term follow-up to monitor lasting effects.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACNE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • DelRicht Research- Site Number : 8400003

    RECRUITING

    New Orleans, Louisiana, 70115, United States

  • Encino Research Center- Site Number : 8400008

    RECRUITING

    Encino, California, 91436, United States

  • Encore Research Group-Jacksonville Center for Clinical Research- Site Number : 8400006

    RECRUITING

    Jacksonville, Florida, 32216, United States

  • Moore Clinical Research - Brandon- Site Number : 8400007

    RECRUITING

    Brandon, Florida, 33511, United States

Conditions

Explore the condition pages connected to this study.